Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Nebulized Glycopyrrolate: A Post Hoc Analysis of Pooled Data from Two Randomized, Double-Blind, Placebo-Controlled Studies

PURPOSE: Using a composite endpoint, pooled data from two 12-week Phase III placebo-controlled trials (GOLDEN 3, NCT02347761; GOLDEN 4, NCT02347774) were analyzed to determine whether glycopyrrolate inhalation solution (25 mcg and 50 mcg) administered twice daily (BID) via the eFlow(®) Closed System...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerwin, Edward M, Murray, Lindsey, Niu, Xiaoli, Dembek, Carole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535937/
https://www.ncbi.nlm.nih.gov/pubmed/33061349
http://dx.doi.org/10.2147/COPD.S267249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535937/
https://www.ncbi.nlm.nih.gov/pubmed/33061349
http://dx.doi.org/10.2147/COPD.S267249

Ejemplares similares